Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma

By Treiber G.   Wex T.   Röcken C.   Fostitsch P.   Malfertheiner P.  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 699-708

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Survival and Prognostic Factors after Pulmonary Metastasectomy in Hepatocellular Carcinoma

By Yoon Yoo  

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2795-2801

Springer Publishing Company

Access to resources Recommend Favorite

Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling

By                  

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 149-154

Spandidos Publications

Access to resources Recommend Favorite

Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival

By Huang G.   Ding X.   Chen S.   Zeng L.  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1213-1218

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival

By Lu Guifang   Shan Tao   He Shuixiang   Ren Mudan   Zhu Meng   Hu Yannan   Lu Xinlan   Zhang Dan  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2238-2244

Spandidos Publications

Access to resources Recommend Favorite